These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38956914)

  • 1. A Rapid, Sensitive, and High-throughput Method for the Simultaneous Determination of Antihypertensive Drug Combinations in Dog Plasma by UHPLC-MS/MS: The Assessment of Predicable Bioequivalence of
    Wang Y; Wang R; Wang H; Liu R; Bi K; Li Q
    Curr Pharm Des; 2024; 30(32):2574-2585. PubMed ID: 38956914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliable and easy-to-use LC-MS/MS-method for simultaneous determination of the antihypertensives metoprolol, amlodipine, canrenone and hydrochlorothiazide in patients with therapy-refractory arterial hypertension.
    Johannsen JO; Reuter H; Hoffmann F; Blaich C; Wiesen MHJ; Streichert T; Müller C
    J Pharm Biomed Anal; 2019 Feb; 164():373-381. PubMed ID: 30439665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of olmesartan medoxomil and hydrochlorothiazide compared with benazepril and amlodipine besylate.
    Kereiakes DJ; Neutel JM; Punzi HA; Xu J; Lipka LJ; Dubiel R
    Am J Cardiovasc Drugs; 2007; 7(5):361-72. PubMed ID: 17953475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous Determination of Aliskiren Hemifumarate, Amlodipine Besylate and Hydrochlorothiazide in Spiked Human Plasma Using UPLC-MS/MS.
    Ebeid WM; Elkady EF; El-Zaher AA; El-Bagary RI; Patonay G
    J Chromatogr Sci; 2015 Aug; 53(7):1178-84. PubMed ID: 25575509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COMPARATIVE BIOAVAILABILITY OF A FIXED-DOSE COMBINATION TABLET OF OLMESARTAN MEDOXOMIL/HYDROCHLOROTHIAZIDE IN HEALTHY KOREAN VOLUNTEERS.
    Zheng R; Hwang HM; Kim BH
    Acta Pol Pharm; 2016; 73(2):509-16. PubMed ID: 27180444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput quantification of 8 antihypertensive drugs and active metabolites in human plasma using UPLC-MS/MS.
    van der Nagel BCH; Versmissen J; Bahmany S; van Gelder T; Koch BCP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():367-373. PubMed ID: 28666228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olmesartan medoxomil/amlodipine/hydrochlorothiazide: fixed-dose combination in hypertension.
    Deeks ED
    Drugs; 2011 Jan; 71(2):209-20. PubMed ID: 21275446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous determination of irbesartan and hydrochlorothiazide in human plasma by ultra high performance liquid chromatography tandem mass spectrometry and its application to a bioequivalence study.
    Qiu X; Wang Z; Wang B; Zhan H; Pan X; Xu RA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Apr; 957():110-5. PubMed ID: 24681823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioequivalence Study of a New Fixed-dose Combination Tablet Containing S-Amlodipine Nicotinate and Olmesartan Medoxomil in Healthy Korean Male Subjects.
    Oh MJ; Hwang HH; Kim HG; Lee GH; Cho YS; Lee SY; Kang SY; Cho KH; Lee YY; Lee YJ; Jang CG; Lee SY
    Clin Ther; 2017 Jul; 39(7):1371-1379. PubMed ID: 28625505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous determination of olmesartan and amlodipine in human plasma and urine by ultra performance liquid chromatography tandem mass spectrometry.
    Qi W; Zhao Q; Jiang J; Hu P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov; 938():27-34. PubMed ID: 24036499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a population pharmacokinetic model to describe olmesartan medoxomil/ hydrochlorothiazide (20/12.5 mg) FDC tablet in male healthy South Korean subjects.
    Chae JW; Baek IH; Seo JW; Jung SH; Back HM; Song BJ; Lee BY; Yun HY; Kang W; Kwon KI
    Int J Clin Pharmacol Ther; 2014 Aug; 52(8):676-83. PubMed ID: 24849193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a stability-indicating UPLC method for the determination of olmesartan medoxomil, amlodipine and hydrochlorothiazide degradation impurities in their triple-combination dosage form using factorial design of experiments.
    Marisetti VM; Katakam P; Siddhani VK; Katari NK
    Biomed Chromatogr; 2021 Nov; 35(11):e5194. PubMed ID: 34110035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioequivalence evaluation of two amlodipine salts, besylate and orotate, each in a fixed-dose combination with olmesartan in healthy subjects.
    Lee SY; Kim JR; Jung JA; Huh W; Bahng MY; Ko JW
    Drug Des Devel Ther; 2015; 9():2811-7. PubMed ID: 26082611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study.
    Oparil S; Melino M; Lee J; Fernandez V; Heyrman R
    Clin Ther; 2010 Jul; 32(7):1252-69. PubMed ID: 20678674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of metoprolol succinate and amlodipine besylate in human plasma by liquid chromatography-tandem mass spectrometry method and its application in bioequivalence study.
    Sarkar AK; Ghosh D; Das A; Selvan PS; Gowda KV; Mandal U; Bose A; Agarwal S; Bhaumik U; Pal TK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Sep; 873(1):77-85. PubMed ID: 18760977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous quantitative determination of olmesartan and hydrochlorothiazide in human plasma and urine by liquid chromatography coupled to tandem mass spectrometry.
    Liu D; Jiang J; Wang P; Feng S; Hu P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Mar; 878(9-10):743-8. PubMed ID: 20153270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of amlodipine and atorvastatin in human plasma by UPLC-MS/MS method and its application to a bioequivalence study.
    Rezk MR; Badr KA
    Biomed Chromatogr; 2018 Jul; 32(7):e4224. PubMed ID: 29498757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of amlodipine, indapamide and perindopril in human plasma by a novel LC-MS/MS method: Application to a bioequivalence study.
    Rezk MR; Badr KA
    Biomed Chromatogr; 2021 May; 35(5):e5048. PubMed ID: 33314205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and Bioequivalence Evaluation of 2 Olmesartan Medoxomil and Amlodipine Besylate Fixed-Dose Combination Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
    Li X; Mo E; Chen L
    Clin Pharmacol Drug Dev; 2022 Jun; 11(6):761-769. PubMed ID: 35289500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Co-Crystallization of Olmesartan Medoxomil and Hydrochlorothiazide for Enhanced Dissolution Rate in Their Fixed Dose Combination.
    Abdelquader MM; Essa EA; El Maghraby GM
    AAPS PharmSciTech; 2018 Dec; 20(1):3. PubMed ID: 30560314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.